Paper42755804
The expression and clinical significance of SIRT5, H2A and TOP2A in cervical cancer.
Li F and 7 others. Front Oncol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. The expression and clinical significance of SIRT5, H2A and TOP2A in cervical cancer. Papers, record 42755804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42755804
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32547216 | TOP2A Promotes Cell Migration, Invasion and Epithelial-Mesenchymal Transition in Cervical Cancer via Activating the PI3K/AKT Signaling. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/32547216 | PubMed |
| 2 | 29491006 | SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer. | EMBO Rep | 2018 | https://conductscience.org/library/papers/29491006 | PubMed |
| 3 | 39979670 | SIRT5: a potential target for discovering bioactive natural products. | J Nat Med | 2025 | https://conductscience.org/library/papers/39979670 | PubMed |
| 4 | 33023625 | TOP2A and CENPF are synergistic master regulators activated in cervical cancer. | BMC Med Genomics | 2020 | https://conductscience.org/library/papers/33023625 | PubMed |
| 5 | 39199381 | The Function of H2A Histone Variants and Their Roles in Diseases. | Biomolecules | 2024 | https://conductscience.org/library/papers/39199381 | PubMed |
| 6 | 38683574 | National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health Centers. | JAMA Intern Med | 2024 | https://conductscience.org/library/papers/38683574 | PubMed |
| 7 | 31769059 | Histone H2A phosphorylation recruits topoisomerase IIα to centromeres to safeguard genomic stability. | EMBO J | 2020 | https://conductscience.org/library/papers/31769059 | PubMed |
| 8 | 26658802 | SUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancer. | Sci Rep | 2015 | https://conductscience.org/library/papers/26658802 | PubMed |
| 9 | 41671440 | Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology. | J Natl Compr Canc Netw | 2025 | https://conductscience.org/library/papers/41671440 | PubMed |
| 10 | 35182732 | Overexpression of SLC25A51 promotes hepatocellular carcinoma progression by driving aerobic glycolysis through activation of SIRT5. | Free Radic Biol Med | 2022 | https://conductscience.org/library/papers/35182732 | PubMed |
| 11 | 38773972 | Mitochondrial Sirtuins in Cancer: A Revisited Review from Molecular Mechanisms to Therapeutic Strategies. | Theranostics | 2024 | https://conductscience.org/library/papers/38773972 | PubMed |
| 12 | 39318140 | Quality of Life Post Cervical Cancer Treatment: A Comparison Between Radical Surgery Approach and Radiotherapy and Chemotherapy. | J Surg Oncol | 2024 | https://conductscience.org/library/papers/39318140 | PubMed |
| 13 | 35576836 | SIRT5 is involved in the proliferation and metastasis of breast cancer by promoting aerobic glycolysis. | Pathol Res Pract | 2022 | https://conductscience.org/library/papers/35576836 | PubMed |
| 14 | 36813074 | Role of SIRT5 in cancer. Friend or Foe? | Biochimie | 2023 | https://conductscience.org/library/papers/36813074 | PubMed |
| 15 | 32782550 | γ-H2AX as a potential indicator of radiosensitivity in colorectal cancer cells. | Oncol Lett | 2020 | https://conductscience.org/library/papers/32782550 | PubMed |
| 16 | 34760688 | H2AFZ Is a Prognostic Biomarker Correlated to TP53 Mutation and Immune Infiltration in Hepatocellular Carcinoma. | Front Oncol | 2021 | https://conductscience.org/library/papers/34760688 | PubMed |
| 17 | 39550837 | Women's ignorance and misperception of cervical cancer: Evidence-based analysis from low- and middle-income countries. | Curr Probl Cancer | 2025 | https://conductscience.org/library/papers/39550837 | PubMed |
| 18 | 39944690 | Emerging roles of mitochondrial sirtuin SIRT5 in succinylation modification and cancer development. | Front Immunol | 2025 | https://conductscience.org/library/papers/39944690 | PubMed |
| 19 | 36322662 | Untangling the roles of TOP2A and TOP2B in transcription and cancer. | Sci Adv | 2022 | https://conductscience.org/library/papers/36322662 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| H2AC18 | 8337 | PubTator's text mining | https://conductscience.org/library/genes/8337 | NCBI Gene |
| SIRT5 | 23408 | PubTator's text mining | https://conductscience.org/library/genes/23408 | NCBI Gene |
| TOP2A | 7153 | PubTator's text mining | https://conductscience.org/library/genes/7153 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42755804
GET https://conductscience.org/api/papers/v1/42755804/authors